Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros













Intervalo de año de publicación
1.
Int Ophthalmol ; 43(10): 3707-3715, 2023 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-37422546

RESUMEN

PURPOSE: This study aimed to explore the role of atorvastatin (ATO) in the prevention and treatment of the scarring of filtration channels after glaucoma surgery. METHODS: Human Tenon's capsule fibroblasts (HTFs) were co-cultured with various concentrations of ATO. First, Cell Counting Kit-8 assay was performed to evaluate the effects of various concentrations of ATO on the viability of HTFs. Then, after the ATO stimulated the HTFs for 24 h, terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay was performed to evaluate the apoptosis of HTFs. Transwell assay was also performed to evaluate the migration of HTFs. Moreover, enzyme-linked immunosorbent assay (ELISA) was performed to detect the protein expression levels of transforming growth factor-ß1 (TGF-ß1) and TGF-ß2 in the cell culture supernatant of HTFs. Western blot was carried out to detect the protein expression levels of smooth muscle actin (SMA), p38, Smad3, fibronectin, collagen I and collagen III in different groups. RESULTS: The results revealed that ATO could inhibit the proliferation and migration of HTFs. Based on the TUNEL assay, 100 µM and 150 µM ATO could induce cell apoptosis. The ELISA results indicated that ATO could down-regulate the expression level of TGF-ß2, and western blot analysis revealed that the protein expression levels of SMA, p38, Smad3, fibronectin, collagen I and collagen III in the TGF-ß2 group were all up-regulated compared with the control group, whereas the addition of ATO could reverse this up-regulation. CONCLUSIONS: ATO could inhibit the proliferation and migration of HTFs and induce their apoptosis. It was preliminary proven that ATO could inhibit the signaling pathway induced by TGF-ß. It is suggested that ATO could be a basis for the treatment of the scarring of filtration channels after glaucoma surgery.


Asunto(s)
Glaucoma , Cápsula de Tenon , Humanos , Cápsula de Tenon/patología , Factor de Crecimiento Transformador beta2/farmacología , Factor de Crecimiento Transformador beta2/metabolismo , Fibronectinas/metabolismo , Fibronectinas/farmacología , Atorvastatina/farmacología , Atorvastatina/metabolismo , Glaucoma/metabolismo , Cicatriz/patología , Células Cultivadas , Fibroblastos , Colágeno/metabolismo , Colágeno Tipo I/metabolismo , Colágeno Tipo I/farmacología , Proliferación Celular
2.
World J Clin Cases ; 11(14): 3187-3194, 2023 May 16.
Artículo en Inglés | MEDLINE | ID: mdl-37274056

RESUMEN

BACKGROUND: The basic method of glaucoma diagnosis is visual field examination, however, in patients with high myopia, the diagnosis of glaucoma is difficult. AIM: To explore the value of optical coherence tomography (OCT) for measuring optic disc parameters and macular thickness as a screening tool for glaucoma in patients with high myopia. METHODS: Visual values (contrast sensitivity, color vision, and best-corrected visual acuity) in three groups, patients with high myopia in Group A, patients with high myopia and glaucoma in Group B, and patients with high myopia suspicious for glaucoma in Group C, were compared. Optic disc parameters, retinal nerve fiber layer (RNFL) thickness, and ganglion cell layer (GCC) thickness were measured using OCT technology and used to compare the peri-optic disc vascular density of the patients and generate receiver operator characteristic (ROC) test performance curves of the RNFL and GCC for high myopia and glaucoma. RESULTS: Of a total of 98 patients admitted to our hospital from May 2018 to March 2022, totaling 196 eyes in the study, 30 patients with 60 eyes were included in Group A, 33 patients with 66 eyes were included in Group B, and 35 patients with 70 eyes were included in Group C. Data were processed for Groups A and B to analyze the efficacy of RNFL and GCC measures in distinguishing high myopia from high myopia with glaucoma. The area under the ROC curve was greater than 0.7, indicating an acceptable diagnostic value. CONCLUSION: The value of OCT measurement of RNFL and GCC thickness in diagnosing glaucoma in patients with high myopia and suspected glaucoma is worthy of development for clinical use.

3.
Can J Physiol Pharmacol ; 100(2): 142-150, 2022 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-34559978

RESUMEN

The endothelial-mesenchymal transition (EndMT) participates in the progression of diabetic retinopathy (DR), but cell-intrinsic factors modulating this process remain elusive. In this study, we explored the role of lysophosphatidic acid (LPA) - producing enzyme, acylglycerol kinase (AGK), in the EndMT of human retinal microvascular endothelial cells (HRECs) under high-glucose (HG) conditions. We found that AGK was significantly elevated in HG-treated cells. In addition, AGK knockdown reversed the HG-induced EndMT in HRECs, which was evidenced by the increased endothelial markers (CD31 and VE-cadherin) and decreased mesenchymal markers (FSP1 and α-SMA). Furthermore, downregulation of AGK inhibited the HG-induced activation of transforming growth factor ß (TGF-ß)/Notch pathways, whereas exogenous TGF-ß1 (10 ng/mL) impeded the inhibitory effects of AGK knockdown on HG-induced EndMT in HRECs. Additionally, the silencing of AGK abolished the HG-induced upregulation of LPA and its receptor, LPA receptor 1 (LPAR1), and overexpression of LPAR1 further rescued the AGK knockdown-mediated inhibition of the EndMT process. In conclusion, we demonstrate that downregulation of AGK suppresses HG-induced EndMT in HRECs through regulating the LPAR1/TGF-ß/Notch signaling pathway, indicating that AGK might be a potential therapeutic target for the treatment of DR.


Asunto(s)
Regulación hacia Abajo/genética , Regulación hacia Abajo/fisiología , Células Endoteliales/fisiología , Transición Epitelial-Mesenquimal/efectos de los fármacos , Transición Epitelial-Mesenquimal/genética , Glucosa/efectos adversos , Fosfotransferasas (Aceptor de Grupo Alcohol)/genética , Fosfotransferasas (Aceptor de Grupo Alcohol)/metabolismo , Receptores del Ácido Lisofosfatídico/genética , Receptores Notch/metabolismo , Vasos Retinianos/citología , Transducción de Señal/genética , Transducción de Señal/fisiología , Factor de Crecimiento Transformador beta/metabolismo , Células Cultivadas , Regulación de la Expresión Génica/genética , Humanos , Receptores del Ácido Lisofosfatídico/metabolismo , Receptores Notch/genética , Factor de Crecimiento Transformador beta/genética
4.
Biol Res ; 52(1): 23, 2019 Apr 16.
Artículo en Inglés | MEDLINE | ID: mdl-30992080

RESUMEN

BACKGROUND: Conjunctival filtering bleb scar formation is the main reason for the failure of glaucoma filtration surgery. Cytoglobin (Cygb) has been reported to play an important role in extracellular matrix (ECM) remodeling, fibrosis and tissue damage repairing. This study aimed to investigate the role of Cygb in anti-scarring during excessive conjunctival wound healing after glaucoma filtration surgery. METHODS: Cygb was overexpressed in human tenon fibroblasts (hTFs) by transfecting hTFs with lentiviral particles encoding pLenti6.2-FLAG-Cygb. Changes in the mRNA and protein levels of fibronectin, collagen I, collagen III, TGF-ß1, and HIF1α were determined by RT-PCR and western blotting respectively. RESULTS: After Cygb overexpression, hTFs displayed no significant changes in visual appearance and cell counts compared to controls. Whereas, Cygb overexpression significantly decreased the mRNA and protein expression levels of collagen I, collagen III and fibronectin compared with control (p < 0.01). There was also a statistically significant decrease in the mRNA and protein levels of TGF-ß1 and HIF-1α in hTFs with overexpressed Cygb compared with control group (p < 0.05). CONCLUSION: Our study provided evidence that overexpression of Cygb decreased the expression levels of fibronectin, collagen I, collagen III, TGF-ß1 and HIF-1α in hTFs. Therefore, therapies targeting Cygb expression in hTFs may pave a new way for clinicians to solve the problem of post-glaucoma surgery scarring.


Asunto(s)
Citoglobina/metabolismo , Matriz Extracelular/metabolismo , Fibroblastos/metabolismo , Cápsula de Tenon/metabolismo , Colágeno/análisis , Citoglobina/farmacología , Matriz Extracelular/efectos de los fármacos , Fibronectinas/análisis , Humanos , ARN Mensajero/análisis , Factor A de Crecimiento Endotelial Vascular/metabolismo
5.
Biol. Res ; 52: 23, 2019. graf
Artículo en Inglés | LILACS | ID: biblio-1011425

RESUMEN

BACKGROUND: Conjunctival filtering bleb scar formation is the main reason for the failure of glaucoma filtration surgery. Cytoglobin (Cygb) has been reported to play an important role in extracellular matrix (ECM) remodeling, fibrosis and tissue damage repairing. This study aimed to investigate the role of Cygb in anti-scarring during excessive conjunctival wound healing after glaucoma filtration surgery. METHODS: Cygb was overexpressed in human tenon fibroblasts (hTFs) by transfecting hTFs with lentiviral particles encoding pLenti6.2-FLAG-Cygb. Changes in the mRNA and protein levels of fibronectin, collagen I, collagen III, TGF-ß1, and HIF1α were determined by RT-PCR and western blotting respectively. RESULTS: After Cygb overexpression, hTFs displayed no significant changes in visual appearance and cell counts compared to controls. Whereas, Cygb overexpression significantly decreased the mRNA and protein expression levels of collagen I, collagen III and fibronectin compared with control (p < 0.01). There was also a statistically significant decrease in the mRNA and protein levels of TGF-ß1 and HIF-1α in hTFs with overexpressed Cygb compared with control group (p < 0.05). CONCLUSION: Our study provided evidence that overexpression of Cygb decreased the expression levels of fibronectin, collagen I, collagen III, TGF-ß1 and HIF-1α in hTFs. Therefore, therapies targeting Cygb expression in hTFs may pave a new way for clinicians to solve the problem of post-glaucoma surgery scarring.


Asunto(s)
Humanos , Matriz Extracelular/metabolismo , Cápsula de Tenon/metabolismo , Fibroblastos/metabolismo , Citoglobina/metabolismo , ARN Mensajero/análisis , Colágeno/análisis , Fibronectinas/análisis , Factor A de Crecimiento Endotelial Vascular/metabolismo , Matriz Extracelular/efectos de los fármacos , Citoglobina/farmacología
6.
J Cell Mol Med ; 22(10): 5008-5019, 2018 10.
Artículo en Inglés | MEDLINE | ID: mdl-30030883

RESUMEN

Oxidative stress can cause injury in retinal endothelial cells. Carboxymethyl cellulose modified with collagen peptide (CMCC) is of a distinct antioxidant capacity and potentially a good drug carrier. In this study, the protective effects of CMCC against H2 O2 -induced injury of primary retinal endothelial cells were investigated. In vitro, we demonstrated that CMCC significantly promoted viability of H2 O2 -treated cells, efficiently restrained cellular reactive oxygen species (ROS) production and cell apoptosis. Then, the CMCC was employed as both drug and anti-inflammatory drug carrier for treatment of retinal ischaemia/reperfusion (I/R) in rats. Animals were treated with CMCC or interleukin-10-loaded CMCC (IL-10@CMCC), respectively. In comparisons, the IL-10@CMCC treatment exhibited superior therapeutic effects, including better restoration of retinal structural thickness and less retinal apoptosis. Also, chemiluminescence demonstrated that transplantation of IL-10@CMCC markedly reduced the retinal oxidative stress level compared with CMCC alone and potently recovered the activities of typical antioxidant enzymes, SOD and CAT. Therefore, it could be concluded that CMCC provides a promising platform to enhance the drug-based therapy for I/R-related retinal injury.


Asunto(s)
Antioxidantes/administración & dosificación , Inflamación/tratamiento farmacológico , Interleucina-10/administración & dosificación , Daño por Reperfusión/tratamiento farmacológico , Retina/efectos de los fármacos , Animales , Antioxidantes/química , Apoptosis/efectos de los fármacos , Carboximetilcelulosa de Sodio/administración & dosificación , Carboximetilcelulosa de Sodio/química , Catalasa/genética , Colágeno/administración & dosificación , Colágeno/química , Portadores de Fármacos/administración & dosificación , Portadores de Fármacos/química , Sistemas de Liberación de Medicamentos , Células Endoteliales/efectos de los fármacos , Células Endoteliales/patología , Humanos , Peróxido de Hidrógeno/toxicidad , Inflamación/patología , Interleucina-10/química , Estrés Oxidativo , Péptidos/administración & dosificación , Péptidos/química , Ratas , Especies Reactivas de Oxígeno/metabolismo , Daño por Reperfusión/inducido químicamente , Daño por Reperfusión/patología , Retina/patología
7.
Int Ophthalmol ; 38(1): 375-379, 2018 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-28108900

RESUMEN

PURPOSE: To introduce a case of ciliary detachment with primary pulmonary hypertension (PPH). METHODS: The clinical manifestations of a case of ciliary detachment with PPH were addressed by comprehensive examination including ultrasound biological microscope (UBM), intraocular pressure, color fundus photographs, fluorescence fundus angiography (FFA). In addition, echocardiography is used to measure primary pulmonary pressure. RESULTS: When the echocardiography displayed a systolic pulmonary arterial pressure of 106 mmHg, UBM exhibited ciliochoroidal detachment, as well as peripheral retinal effusion and non-perfusion areas in FFA. After well controlled of PPH, UBM showed normal ciliary body. FFA confirmed that retinal effusion disappeared. CONCLUSIONS: The elevated venous pressure in PPH is responsible for decreased choroidal backflow and reduced venous blood outflow from the eye. PPH would contribute to the clinical manifestations of severe choroidal detachment and peripheral retina effusion in this patient.


Asunto(s)
Cuerpo Ciliar , Hipertensión Pulmonar Primaria Familiar/complicaciones , Angiografía con Fluoresceína/métodos , Retina/patología , Desprendimiento de Retina/etiología , Adulto , Coroides/patología , Diagnóstico Diferencial , Ecocardiografía , Hipertensión Pulmonar Primaria Familiar/diagnóstico , Femenino , Fondo de Ojo , Humanos , Presión Esfenoidal Pulmonar , Desprendimiento de Retina/diagnóstico , Agudeza Visual
8.
Graefes Arch Clin Exp Ophthalmol ; 253(6): 875-84, 2015 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-25875044

RESUMEN

BACKGROUND: The formation of scar-like fibrous tissue in age-related macular degeneration (AMD) is associated with hypoxia. Under hypoxia, retinal pigment epithelial (RPE) cells can secret more transforming growth factor-ß2 (TGF-ß2), which is determined to induce epithelial-mesenchymal transition (EMT) at certain concentrations. Whether hypoxia can induce EMT by stimulating RPE cell line secrets TGF-ß2 or not remains unknown. To gain a better understanding of the signaling mechanisms of fibrosis in AMD under hypoxic conditions, we investigated EMT in retinal pigment epithelial (RPE) cells and the effect of TGF-ß2 and Snail in this process. METHODS: Human RPE cell line (ARPE-19) was incubated with 5 % O2 for different periods of time. The expression of N-cadherin, α-smooth muscle actin (α-SMA), TGF-ß2 , and Snail were determined by Western blot and real-time PCR. Cell proliferation was assessed by CCK8 kit. RNA interference was used for multi-gene silencing of TGF-ß2 and Snail genes. RESULTS: N-cadherin was decreased and mesenchymal cell marker α-SMA was increased after the ARPE-19 cell line was incubated with 5 % O2. Meanwhile, the proliferation capability of the cell line was increased. TGF-ß2 and Snail expression were increased in a time-dependent manner under hypoxia. After multi-silencing TGF-ß2 and Snail genes, N-cadherin was increased and α-SMA was reduced. Meanwhile, the proliferation of the cell line was suppressed. CONCLUSIONS: Under hypoxic conditions, RPE cells undergo EMT. Endogenic TGF-ß2 and Snail are involved in this process. Furthermore, knockdown of both TGF-ß2 and Snail inhibited EMT to a greater extent than knockdown of either gene individually.


Asunto(s)
Transición Epitelial-Mesenquimal/fisiología , Silenciador del Gen/fisiología , Hipoxia/metabolismo , Epitelio Pigmentado de la Retina/citología , Factores de Transcripción/genética , Factor de Crecimiento Transformador beta2/genética , Actinas/genética , Actinas/metabolismo , Antígenos CD/genética , Antígenos CD/metabolismo , Western Blotting , Cadherinas/genética , Cadherinas/metabolismo , Línea Celular , Proliferación Celular , Humanos , ARN Mensajero/genética , Reacción en Cadena en Tiempo Real de la Polimerasa , Epitelio Pigmentado de la Retina/metabolismo , Factores de Transcripción de la Familia Snail , Factores de Transcripción/metabolismo , Transfección , Factor de Crecimiento Transformador beta2/metabolismo
9.
Mol Biol Rep ; 36(8): 2147-51, 2009 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-19107574

RESUMEN

To explore the effect of high glucose concentration on the expression of vascular endothelial growth factor (VEGF) and pigment epithelium derived factor (PEDF) in the cultured rat retinal Müller cells. Rat Müller cells were cultured and RT-PCR and Western-blot analysis were used to measure the levels of VEGF and PEDF in cultured Müller cells at different high glucose concentrations. Under 10, 20, 30 mmol/L high glucose conditions, the levels of VEGF mRNA and protein increased and the levels of PEDF mRNA and protein decreased. These results suggest that the VEGF and PEDF expression in Müller cells are unbalance under high glucose concentration, which contribute to retinal neovascularization in diabetic retinopathy.


Asunto(s)
Proteínas del Ojo/biosíntesis , Glucosa/farmacología , Factores de Crecimiento Nervioso/biosíntesis , Retina/efectos de los fármacos , Serpinas/biosíntesis , Factor A de Crecimiento Endotelial Vascular/biosíntesis , Animales , Células Cultivadas , Proteínas del Ojo/genética , Expresión Génica/efectos de los fármacos , Inmunohistoquímica , Factores de Crecimiento Nervioso/genética , ARN Mensajero/genética , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Retina/citología , Retina/metabolismo , Serpinas/genética , Factor A de Crecimiento Endotelial Vascular/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA